Skip to content
10-Q

Quarterly Report

SAB Biotherapeutics, Inc. SABS SABSW

0000950170-25-104566

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 10.41M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.29M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.29M sh
Shares Diluted Q2 2025 · Jun 30, 2024 9.26M sh
Shares Diluted Q2 2025 · Jun 30, 2024 9.25M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$14.95M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$18.47M
Short Term Investments Q2 2025 · Jun 30, 2025 $2.02M
Short Term Investments Q2 2025 · Dec 31, 2024 $11.86M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.69M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $8.9M
Stockholders Equity Q2 2025 · Jun 30, 2025 $12.02M
Stockholders Equity Q2 2025 · Mar 31, 2025 $21.41M
Stockholders Equity Q2 2025 · Dec 31, 2024 $25.97M
Stockholders Equity Q2 2025 · Jun 30, 2024 $46.12M
Stockholders Equity Q2 2025 · Mar 31, 2024 $52.82M
Stockholders Equity Q2 2025 · Dec 31, 2023 $57.3M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $7.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $18.11M
Total Liabilities Q2 2025 · Dec 31, 2024 $18.23M
Current Assets Q2 2025 · Jun 30, 2025 $9.31M
Current Assets Q2 2025 · Dec 31, 2024 $23.79M
Total Assets Q2 2025 · Jun 30, 2025 $30.13M
Total Assets Q2 2025 · Dec 31, 2024 $44.2M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.09
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.65
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.79
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.34
Eps Basic Q2 2025 · Jun 30, 2025 −$1.09
Eps Basic Q2 2025 · Jun 30, 2025 −$1.65
Eps Basic Q2 2025 · Jun 30, 2024 −$0.79
Eps Basic Q2 2025 · Jun 30, 2024 −$1.34
Sga Expense Q2 2025 · Jun 30, 2025 $2.74M
Sga Expense Q2 2025 · Jun 30, 2025 $5.85M
Sga Expense Q2 2025 · Jun 30, 2024 $3.64M
Sga Expense Q2 2025 · Jun 30, 2024 $8.03M
Rd Expense Q2 2025 · Jun 30, 2025 $7M
Rd Expense Q2 2025 · Jun 30, 2025 $14.65M
Rd Expense Q2 2025 · Jun 30, 2024 $6.82M
Rd Expense Q2 2025 · Jun 30, 2024 $14.77M
Net Income Q2 2025 · Jun 30, 2025 −$10.11M
Net Income Q2 2025 · Jun 30, 2025 −$15.31M
Net Income Q2 2025 · Mar 31, 2025 −$5.2M
Net Income Q2 2025 · Jun 30, 2024 −$7.34M
Net Income Q2 2025 · Jun 30, 2024 −$12.36M
Net Income Q2 2025 · Mar 31, 2024 −$5.03M
Operating Income Q2 2025 · Jun 30, 2025 −$9.73M
Operating Income Q2 2025 · Jun 30, 2025 −$20.5M
Operating Income Q2 2025 · Jun 30, 2024 −$10.2M
Operating Income Q2 2025 · Jun 30, 2024 −$21.59M
Capex Q2 2025 · Jun 30, 2024 $181.59K
Revenue Q2 2025 · Jun 30, 2024 $263.14K
Revenue Q2 2025 · Jun 30, 2024 $1.21M